Top in rheumatology: Osteoporosis controversies, COVID-19 PrEP
Click Here to Manage Email Alerts
A speaker at the 2021 Congress of Clinical Rheumatology-West shared how some osteoporosis guidelines conflict, leading to debates in the management of the disease.
His presentation, as well as other conference highlights, made up many of the top stories in rheumatology last week.
Another top story was a column from Leonard H. Calabrese, DO, the Chief Medical Editor of Healio Rheumatology, where he strongly encouraged regulators to make certain COVID-19 therapies available to some patients as soon as possible.
Read these and more top stories in rheumatology below:
Conflicting guidelines highlight controversies in osteoporosis management
Discrepancies between clinical practice guideline documents highlight the over-arching controversies in osteoporosis management, according to a presenter at the 2021 Congress of Clinical Rheumatology-West. Read more.
COVID-19 PrEP for immunosuppressed patients: The time is now
In this column, Leonard H. Calabrese, DO, Chief Medical Editor of Healio Rheumatology, professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and RJ Fasenmyer Chair of Clinical Immunology at the Cleveland Clinic, discussed the importance of making certain COVID-19 therapies immediately “available on a compassionate use basis” to some patients. Read more.
Fibromyalgia diagnosis may be confounded by small fiber neuropathy
Small fiber neuropathy, a pain-inducing condition that resembles and overlaps with fibromyalgia, may be significantly under-diagnosed in the U.S., according to a presenter at the 2021 Congress of Clinical Rheumatology-West. Read more.
'Tips and tricks' for improving diagnosis, treatment of musculoskeletal disease
A reminder of some common and not-so-common clinical scenarios can make every rheumatologist more capable of delivering optimal patient care, according to a presenter at the 2021 Congress of Clinical Rheumatology-West. Read more.
Concerns linger for ‘problematic’ 2021 ACR RA guidelines
While the 2021 American College of Rheumatology rheumatoid arthritis recommendations improved over the 2015 document, understanding the weaknesses and limitations of the most recent iteration can be beneficial, according to a presenter at the 2021 Congress of Clinical Rheumatology-West. Read more.